Track: Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

Heart 2025 Conference - Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

Nuclear cardiology, molecular cardiology, and cardio-oncology represent dynamic fields addressing complex cardiovascular challenges. Nuclear cardiology leverages advanced imaging techniques like PET and SPECT to evaluate myocardial function, perfusion, and viability. Molecular cardiology focuses on genetic, epigenetic, and cellular mechanisms driving cardiovascular diseases, paving the way for precision medicine.

Cardio-oncology, an evolving specialty, addresses the cardiovascular risks associated with cancer treatments such as chemotherapy and radiation therapy. With cancer survivors at increased risk of heart failure, arrhythmias, and vascular complications, this discipline plays a crucial role in balancing effective cancer care with optimal cardiovascular health.

Emerging trends include the integration of AI in nuclear imaging, molecular-level interventions using RNA-based therapies, and cardio-oncology strategies such as protective pharmacology and early risk stratification. The session also examines the growing market for personalized medicine in cardiology and oncology.

Key Topics to Be Discussed:

1. Advances in Nuclear Cardiology Imaging
This segment will explore the latest in PET, SPECT, and hybrid imaging modalities for assessing coronary artery disease, heart failure, and viability. Discussions will include AI-driven image analysis and its role in enhancing diagnostic accuracy.

2. Molecular Insights into Cardiovascular Diseases
Discover how molecular cardiology is advancing our understanding of genetic predispositions, epigenetic modifications, and signaling pathways in heart disease. This segment will focus on RNA-based therapies and gene-editing tools like CRISPR for precision interventions.

3. Cardio-Oncology: Managing Cancer Therapy-Induced Cardiotoxicity
This segment focuses on identifying and managing cardiotoxic effects of cancer treatments, including anthracyclines and immunotherapies. Topics include protective pharmacological agents, early detection strategies using biomarkers and imaging, and multidisciplinary care models.

4. AI and Digital Tools in Cardiovascular Imaging
Explore the role of artificial intelligence and machine learning in revolutionizing nuclear cardiology. This discussion will cover AI applications in myocardial perfusion imaging, automating workflows, and reducing diagnostic variability.

5. Future Directions in Personalized Medicine
Learn about personalized approaches integrating molecular diagnostics, predictive models, and tailored therapies to improve outcomes in both cardiology and oncology patients. This segment will discuss challenges in clinical adoption and market potential.

Summary:

This session bridges advanced imaging, molecular research, and cardio-oncology to provide attendees with:
Knowledge of cutting-edge nuclear imaging techniques and their clinical applications.
Insights into molecular-level interventions driving the future of cardiology.
Practical approaches for managing cardiotoxicity in cancer patients.
Understanding the integration of AI in imaging and diagnosis for precision care.
Exposure to personalized medicine strategies for tailored patient care.

Attendees will gain actionable expertise to adopt these innovative approaches in their practices, ensuring comprehensive and multidisciplinary care for complex cardiovascular and oncological conditions.